# Goal-Directed Fluid Therapy in Sepsis: Resuscitation, Optimization, and Maintenance ## Key Takeaways - Goal-directed fluid therapy in sepsis is structured into three phases: resuscitation, optimization, and maintenance, each with distinct objectives and monitoring parameters to restore and maintain tissue perfusion. - Resuscitation focuses on rapid restoration of perfusion pressure and oxygen delivery using boluses of balanced isotonic crystalloids, guided by parameters like heart rate, blood pressure, lactate, and central venous oxygen saturation (ScvO₂), with fluid intolerance identified by worsening respiratory effort or rising central venous pressure. - The optimization phase aims to match oxygen delivery to demand and clear lactate by continuing fluid administration at a slower rate, guided by trends in lactate clearance, ScvO₂, and base deficit, while actively monitoring for signs of fluid overload such as increased respiratory effort or weight gain. - Maintenance phase fluid therapy replaces ongoing losses and basal requirements, with daily body weight measurement being critical to detect fluid accumulation (weight gain >5% above admission weight) and prompt fluid reduction or cessation. - Species differences, particularly in cats, necessitate adapted monitoring strategies, with less reliance on heart rate and greater emphasis on blood pressure, lactate, and urine output due to their propensity for pulmonary edema and bradycardia. - Key failure modes include under-resuscitation leading to irreversible shock, fluid overload causing pulmonary and tissue edema, and failure to recognize iatrogenic volume excess, highlighting the importance of continuous reassessment and explicit stopping criteria. --- Sepsis and septic shock remain among the most resource-intensive and mortality-associated conditions managed in veterinary emergency and critical care. Fluid administration is the first therapeutic intervention in most septic patients, yet the volume, rate, and monitoring strategy determine whether fluids restore perfusion or contribute to harm. This article provides a procedural framework for goal-directed fluid therapy across the resuscitation, optimization, and maintenance phases in dogs and cats with sepsis. It is written for practicing veterinarians who need explicit decision criteria, monitoring parameters, and failure modes instead of general exhortations to "fluid resuscitate." The clinical question addressed is direct: how does the clinician titrate fluid therapy to measurable endpoints, when does fluid administration cease being therapeutic, and what distinguishes the three phases of fluid management in the septic patient? The framework presented here integrates consensus guidance from the AAHA and AAFP fluid therapy guidelines with published veterinary ICU data on tissue perfusion targets. Species differences between dogs and cats are highlighted where they alter clinical decisions. Specific drug dosing, non-sepsis causes of shock, and cardiopulmonary resuscitation protocols are outside the scope of this article. ## At a Glance | Parameter | Resuscitation Phase | Optimization Phase | Maintenance Phase | |---|---|---|---| | Primary goal | Restore perfusion pressure and tissue oxygen delivery | Match oxygen delivery to demand, clear lactate | Replace ongoing losses, avoid overload | | Typical monitoring | Heart rate, blood pressure, lactate, central venous oxygen saturation | Lactate clearance, ScvO2 trends, base deficit, urine output | Body weight, fluid balance, lung auscultation, central venous pressure | | Fluid selection | Balanced isotonic crystalloids | Crystalloids, colloids considered for refractory hypotension | Crystalloids with electrolytes matched to losses | | Stopping criteria | Normotension, improved perfusion, lactate falling | Lactate normalization, ScvO2 above threshold, no ongoing organ dysfunction | Positive balance with no further losses, weaning fluids | | Principal risk | Under-resuscitation, irreversible shock | Fluid overload, pulmonary edema, tissue edema | Overload, electrolyte derangement | | Key failure mode | Persistent hypotension despite volume | Continued fluid administration after perfusion restored | Failure to recognize iatrogenic volume excess | ## Pathophysiology of Sepsis and the Rationale for Goal-Directed Therapy Sepsis produces a characteriztic combination of vasodilation, relative and absolute hypovolemia, endothelial dysfunction, and microcirculatory derangement. Capillary leakage driven by inflammatory mediators moves fluid from the intravascular space into the interstitium, reducing effective circulating volume even when total body water is normal or increased. Simultaneously, arterial vasodilation lowers systemic vascular resistance, and myocardial depression may reduce cardiac output. The net hemodynamic picture is a patient who needs volume to fill a dilated vascular bed, but whose leaky endothelium makes retained fluid a hazard. The microcirculation behaves independently of macrocirculatory parameters. Blood pressure and cardiac output can appear adequate while tissue perfusion remains compromised, a phenomenon recognized in human sepsis research and relevant to veterinary patients. This dissociation explains why resuscitation guided solely by blood pressure is insufficient. Goal-directed therapy uses composite endpoints that reflect tissue oxygenation, including lactate, central venous oxygen saturation (ScvO2), and base deficit, instead of relying on any single pressure measurement. ## The Three-Phase Model of Fluid Therapy Fluid therapy in sepsis is best conceptualized as three sequential but overlapping phases: resuscitation, optimization, and maintenance. Each phase has distinct objectives, monitoring priorities, and termination criteria. The phases are not rigid compartments. A patient who deteriorates during optimization may return to the resuscitation phase, and a patient in maintenance may require a rescue bolus if perfusion decompensates. ### Resuscitation Phase The resuscitation phase addresses immediate, life-threatening hypoperfusion. The objective is to restore effective circulating volume rapidly enough to prevent irreversible cellular injury. In dogs with severe sepsis or septic shock, admission values of ScvO2, lactate, and base deficit each independently predict death, which supports using these parameters as resuscitation targets from the moment of ICU admission. The clinician should establish baseline values for these parameters before initiating fluid therapy whenever practical. Resuscitation proceeds with rapid administration of isotonic crystalloids delivered as discrete boluses instead of a continuous infusion. Each bolus is followed by reassessment of perfusion parameters. The bolus-and-reassess cycle continues until perfusion endpoints are met or until the patient shows signs of fluid intolerance. Fluid intolerance manifests as worsening respiratory effort, crackles on thoracic auscultation, or rising central venous pressure without corresponding improvement in perfusion. The AAHA and AAFP fluid therapy guidelines emphasize that the decision to continue resuscitation must be based on reassessment after each bolus, not on a predetermined total volume. ### Optimization Phase The optimization phase begins when the patient is no longer in immediate danger of cardiovascular collapse but still demonstrates evidence of inadequate tissue perfusion. The distinction from resuscitation is one of tempo and endpoints. Resuscitation asks whether the patient is perfused enough to survive the next hour. Optimization asks whether oxygen delivery is sufficient to clear lactate and reverse organ dysfunction. During optimization, fluid administration continues at a slower rate, guided by trends instead of single measurements. Lactate clearance is the most practical serial endpoint in veterinary patients. A falling lactate indicates that oxygen delivery now exceeds demand. ScvO2 provides complementary information about the balance between oxygen delivery and consumption, and base deficit tracks the resolution of metabolic acidosis. The clinician should establish a monitoring interval and reassess the trajectory of these parameters, also their absolute values. The optimization phase is where the risk of fluid overload becomes clinically significant. Human critical care data demonstrate that fluid overload and positive cumulative fluid balance are associated with increased mortality, and the same biological plausibility applies to veterinary patients. The clinician must therefore ask after each fluid increment whether the patient still has a perfusion deficit that fluids will correct. If lactate is falling and ScvO2 is adequate, additional fluid does not improve outcome and may cause harm. ### Maintenance Phase The maintenance phase addresses ongoing losses and basal requirements once perfusion is restored. The patient in this phase has normalized or near-normalized perfusion parameters and requires fluids only to replace insensible losses, ongoing gastrointestinal or renal losses, and any residual deficit that could not be corrected during earlier phases without causing overload. Maintenance fluids are administered at calculated rates based on body weight and estimated losses, with electrolyte composition matched to the patient's measured abnormalities. Daily body weight measurement is the single most useful monitoring tool in this phase. Weight gain exceeding 5% above admission weight indicates fluid accumulation and should prompt reduction or cessation of fluids. The AAHA and AAFP guidelines recommend active de-escalation of fluid therapy as soon as the patient no longer demonstrates a perfusion deficit, with transition to enteral water intake as soon as the patient can drink. ## Species Considerations in Dogs and Cats Dogs and cats differ in their hemodynamic responses to sepsis and in their tolerance for volume loading. Cats are more prone to pulmonary edema with aggressive fluid administration and often require smaller boluses with longer reassessment intervals. Feline sepsis frequently presents with bradycardia or normal heart rate instead of tachycardia, which removes heart rate as a reliable perfusion indicator in this species. The MSD Veterinary Manual notes that cats may show hypothermia and depression instead of the classic hyperdynamic picture seen in dogs. Clinicians should adapt monitoring strategies accordingly, placing greater weight on blood pressure, lactate, and urine output in cats and less on heart rate trends. ## Limitations of the Evidence Base The veterinary literature on goal-directed fluid therapy in sepsis is limited. The most directly relevant study, a prospective observational investigation of dogs with pyometra-associated sepsis, demonstrated that tissue perfusion parameters measured at ICU admission relate independently to outcome, but it did not establish that protocolized resuscitation improves survival. Extrapolation from human critical care data must be tempered by species differences in cardiovascular physiology and by the heterogeneity of sepsis sources in veterinary patients. The clinician should treat the framework presented here as a structured approach to monitoring and decision-making, not as a validated protocol with proven survival benefit. ## Clinical Assessment and Resuscitation Endpoints The transition from recognition to action in septic shock requires a structured assessment that pairs global hemodynamic variables with tissue perfusion markers. In dogs with severe sepsis or septic shock, admission values for central venous oxygen saturation (ScvO₂), lactate, and base deficit each relate independently to outcome, which supports using these parameters as resuscitation targets instead of as passive prognostic scores [Conti-Patara et al., changes in tissue perfusion parameters in dogs with severe sepsis](https://pubmed.ncbi.nlm.nih.gov/22731982/). The initial assessment should establish four domains simultaneously: perfusion adequacy, oxygenation status, volume responsiveness, and the presence of ongoing fluid losses. Perfusion adequacy is judged from mucous membrane color, capillary refill time, pulse quality, heart rate, and mental status. Oxygenation status requires pulse oximetry or arterial blood gas analysis when available. Volume responsiveness is best assessed dynamically, using passive leg raise in recumbent patients, respiratory variation in vena caval diameter on ultrasound, or pulse pressure variation in mechanically ventilated patients. Static measurements such as central venous pressure (CVP) have limited predictive value for volume responsiveness but remain useful as safety limits during resuscitation. Lactate measurement deserves particular emphasis. A venous lactate sample obtained at presentation, followed by serial measurements every 2 to 4 hours during the resuscitation phase, provides an objective index of tissue hypoxia and perfusion improvement. The goal is a downward trend toward reference interval, not necessarily normalization within the first hours. Base deficit serves a similar role and is particularly useful when lactate measurement is unavailable. ## Protocol Structure for the Resuscitation Phase Resuscitation proceeds in defined increments with reassessment after each step. A common structure uses 10 to 20 mL/kg boluses of balanced isotonic crystalloid administered over 15 to 30 minutes in dogs, with smaller increments of 5 to 10 mL/kg in cats. After each bolus, reassess perfusion parameters, heart rate, blood pressure, and respiratory effort before deciding whether additional volume is needed. The decision to stop fluid resuscitation and initiate vasopressor support rests on specific criteria. If perfusion parameters fail to improve after two or three boluses, or if blood pressure remains below the species-specific target despite adequate volume administration, vasopressors should be started. In dogs, mean arterial pressure targets of 65 to 70 mm Hg are commonly used. Cats present a greater challenge because they tolerate volume overload poorly and often require earlier vasopressor support. Fluid selection during resuscitation favors balanced isotonic crystalloids over 0.9% saline. Hyperchloremia from saline administration can contribute to metabolic acidosis and reduced renal perfusion. Synthetic colloids have fallen out of favor in sepsis resuscitation due to concerns about coagulation and renal effects, and their routine use is not supported by current evidence. Blood products should be considered when anemia or coagulopathy contributes to inadequate oxygen delivery. ## Monitoring Parameters and Their Interpretation | Parameter | Target | Frequency | What It Detects | Action If Abnormal | |---|---|---|---|---| | Lactate | Downward trend toward reference interval | Every 2 to 4 hours during resuscitation | Tissue hypoxia, perfusion adequacy | Continue resuscitation, reassess source control | | Central venous oxygen saturation (ScvO₂) | Greater than 70% in dogs | Every 4 to 6 hours | Balance between oxygen delivery and consumption | Increase oxygen delivery, check hemoglobin and cardiac output | | Central venous pressure (CVP) | 0 to 5 cm H₂O in spontaneously breathing dogs, use as safety limit, not target | Before and after each bolus | Volume status trend, right heart tolerance | Stop boluses if CVP rises more than 5 cm H₂O | | Mean arterial pressure | 65 to 70 mm Hg in dogs | Continuous or every 15 minutes | Perfusion pressure | Initiate or escalate vasopressors | | Urine output | Greater than 1 to 2 mL/kg/hour in dogs | Hourly via urinary catheter | Renal perfusion, global perfusion | Reassess volume status, consider vasopressor support | | Base deficit | Improving toward reference interval | Every 4 to 6 hours | Metabolic acidosis from hypoperfusion | Continue resuscitation, reassess source control | | Respiratory effort and lung sounds | No increase in effort, no crackles | Every 30 to 60 minutes | Fluid overload, pulmonary edema | Slow or stop fluids, consider diuretics | The monitoring plan must adapt to available equipment. A practice with an ultrasound machine and urinary catheters can track vena caval diameter and urine output. A practice without these resources relies on serial lactate, blood pressure, heart rate, and respiratory assessment. The absence of advanced monitoring does not preclude goal-directed therapy, but it narrows the margin of safety and should lower the threshold for vasopressor initiation. ## The Optimization Phase in Practice Once the patient is hemodynamically stabilized, the optimization phase begins. This phase addresses persistent tissue hypoperfusion that may remain despite normalized blood pressure and heart rate. The microcirculation can remain dysfunctional even when global hemodynamic parameters appear satisfactory, a phenomenon recognized in sepsis and relevant to resuscitation strategy [Naumann et al., protocol for a systematic review of resuscitation fluids and the microcirculation](https://pubmed.ncbi.nlm.nih.gov/26437713/). During optimization, fluid administration continues at a reduced rate, typically as a maintenance-plus-replacement strategy instead of bolus therapy. The goals shift from rapid restoration of perfusion to gradual correction of remaining deficits while avoiding fluid accumulation. Serial lactate and ScvO₂ measurements guide this phase. If lactate fails to clear despite adequate blood pressure and perfusion, investigate alternative causes: ongoing source of infection, inadequate source control, anemia, or cardiac dysfunction. The optimization phase is also the time to reassess the initial fluid prescription. Calculate the patient's maintenance requirements, estimate ongoing losses from vomiting, diarrhea, or third-space sequestration, and adjust the infusion rate accordingly. The [AAHA/AAFP fluid therapy guidelines for dogs and cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) emphasize individualized rate planning with frequent reassessment instead of fixed formulas. ## The Maintenance Phase and Fluid Overload Avoidance The maintenance phase begins when perfusion parameters have normalized and the patient no longer requires active hemodynamic support. The objective shifts from resuscitation to meeting daily requirements while allowing the patient to mobilize and excrete the fluids administered during resuscitation. This phase is where fluid overload becomes the dominant risk. Fluid overload, defined as weight gain greater than 5% or a positive cumulative fluid balance, is associated with increased mortality in critically ill patients [Messmer et al., fluid overload and mortality in adult critical care patients](https://pubmed.ncbi.nlm.nih.gov/33009098/). The same principle applies to veterinary patients. Daily weighing is the most reliable method for detecting fluid accumulation and should be performed at least once daily in hospitalized septic patients. A patient gaining more than 1% to 2% of body weight per day while receiving maintenance fluids is accumulating fluid and requires prescription adjustment. The maintenance phase should also prompt a deliberate de-resuscitation strategy. Once the patient is hemodynamically stable, consider reducing the fluid rate, transitioning from intravenous to enteral water intake as the patient recovers, and using diuretics if fluid overload is documented. The decision to stop intravenous fluids should be based on the patient's ability to maintain hydration and perfusion without them, not on a predetermined duration of therapy. ## Troubleshooting Fluid Overload During Resuscitation Fluid overload can develop during any phase, and early recognition prevents progression to pulmonary edema and tissue edema that impairs oxygen diffusion. Clinical signs include increased respiratory effort, crackles on thoracic auscultation, chemosis, peripheral edema, and a rising CVP. In cats, even modest volume excess can precipitate respiratory distress, so monitoring must be particularly vigilant. When fluid overload is suspected, stop bolus administration immediately. Reassess perfusion parameters to determine whether vasopressor support is needed to maintain blood pressure without additional volume. If the patient remains hypotensive and volume-overloaded, vasopressors are the appropriate next step, not more fluid. In severe cases with pulmonary edema, furosemide may be indicated, but only after confirming that hypoperfusion is not the primary problem. The [RECOVER veterinary CPR guidelines](https://recoverinitiative.org/) address the extreme consequence of resuscitation failure, cardiac arrest, and emphasize that post-arrest care includes careful reassessment of volume status. Patients who arrest during sepsis resuscitation often have received substantial fluid volumes, and post-arrest management must account for the possibility of iatrogenic fluid overload. Documentation of fluid therapy should include the indication for each bolus, the volume administered, the patient's response, and the monitoring parameters that guided the decision. This record supports clinical reasoning, facilitates communication among team members, and provides the data needed to adjust the plan as the patient's condition evolves. ## Recognized Complications and Early Detection Fluid overload remains the most common iatrogenic complication of sepsis resuscitation. In critically ill patients, cumulative positive fluid balance and weight gain above 5% are each independently associated with increased mortality, with adjusted relative risk for fluid overload reported at 8.83 after three days of ICU stay in human observational data. The [AAHA/AAFP fluid therapy guidelines for dogs and cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) recommend serial body weight measurement as the most reliable bedside indicator of fluid accumulation. Weigh the patient at least twice daily on the same scale, and track the trend instead of a single reading. Pulmonary edema develops when hydrostatic pressure exceeds oncotic and lymphatic clearance capacity. Detect it early through increased respiratory effort, auscultatory crackles, and declining SpO2 before overt tachypnoea appears. In cats, subtle changes in respiratory pattern or posture, such as tucking or open-mouth breathing, may precede auscultatory changes. Peripheral edema, chemosis, and serous nasal discharge indicate interstitial overload that has already progressed. Tissue edema impairs oxygen diffusion and worsens microcirculatory dysfunction. The [systematic review protocol on resuscitation fluids and the microcirculation](https://pubmed.ncbi.nlm.nih.gov/26437713/) notes that microcirculatory derangement can persist despite restoration of global hemodynamic parameters, which means normal blood pressure does not exclude ongoing tissue hypoperfusion. Serial lactate and central venous oxygen saturation (ScvO2) trends provide the earliest warning that resuscitation targets are not being met. In dogs with severe sepsis or septic shock, ScvO2, lactate, and base deficit measured at ICU admission each relate independently to death, supporting their use as outcome-relevant monitoring parameters. Coagulopathy from hemodilution and consumptive coagulopathy may present as prolonged bleeding from venepuncture sites, petechiae, or worsening anemia without visible blood loss. Monitor platelet count, prothrombin time, and activated partial thromboplastin time in any septic patient receiving large-volume resuscitation. ## Common Errors and Corrective Actions Less experienced clinicians frequently mistake initial hemodynamic improvement for completed resuscitation. A single normal blood pressure reading after a fluid bolus does not confirm adequate perfusion. Reassess perfusion parameters, including lactate clearance, within one to two hours of each intervention. Another recurring error is continuing bolus therapy after perfusion targets are met but blood pressure remains marginally low. This reflects failure to distinguish hypovolemia from vasoplegia. If central venous pressure rises without corresponding improvement in blood pressure, cardiac output, or perfusion markers, stop fluid boluses and consider vasopressor support. Under-resuscitation in the first hour remains more common than over-resuscitation in veterinary sepsis. Delaying initial boluses while awaiting diagnostic confirmation allows irreversible tissue injury. Conversely, continuing aggressive boluses beyond the first few hours without reassessment produces the fluid overload patterns described above. The corrective action is the same in both directions: protocolised reassessment at fixed intervals with explicit stopping rules. Clinicians also overlook the contribution of maintenance fluids to cumulative volume. Once resuscitation and optimization are complete, reduce or discontinue maintenance fluids instead of continuing them at standard rates. The [RECOVER veterinary CPR guidelines](https://recoverinitiative.org/) similarly emphasize protocolised, time-stamped decision points during resuscitation, a principle that transfers directly to sepsis fluid management. ## Limitations of the Evidence and Areas of Expert Disagreement The veterinary evidence base for goal-directed fluid therapy in sepsis rests largely on observational data. The prospective study of dogs with pyometra-associated sepsis demonstrated associations between perfusion parameters and outcome, but it did not compare goal-directed therapy against standard care in a randomised design. Whether protocolised resuscitation improves survival over careful unstructured assessment remains unproven in dogs and cats. Expert opinion diverges on optimal fluid choice, resuscitation rate, and the role of colloids. Crystalloid remains the default resuscitation fluid in most veterinary protocols, but the ideal volume and rate are not established. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) presents balanced crystalloids as first-line therapy while acknowledging that individual patient factors may alter this choice. The optimal target for ScvO2 in dogs and cats is extrapolated from human critical care and may not reflect species-specific oxygen delivery requirements. Similarly, the ideal lactate clearance rate in veterinary sepsis is not defined. Some clinicians target normalization of lactate within six hours, while others accept a 10% per hour reduction. Neither approach has direct veterinary validation. Fluid overload definitions also vary. The human threshold of 5% weight gain may not translate directly to veterinary patients with differing body composition and fluid distribution. Until species-specific thresholds are established, use trends in weight, perfusion parameters, and respiratory status together instead of any single cutoff. ## Referral, Consultation, and Reporting Refer patients to a 24-hour critical care facility when perfusion targets cannot be met within two to three hours of presentation, when vasopressor support is required, or when the patient develops progressive organ dysfunction despite resuscitation. Earlier referral is appropriate when the practice lacks continuous monitoring capability, blood gas analysis, or the ability to provide overnight care. Specialist consultation is warranted for persistent lactic acidosis without identifiable source, suspected abdominal or thoracic sepsis requiring advanced imaging or surgical intervention, and cases where fluid overload complicates ongoing resuscitation. Clinical pathologists can assist with interpretation of serial coagulation profiles and with distinguishing sepsis-associated coagulopathy from other causes. Regulatory reporting obligations vary by jurisdiction. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) govern notification of certain zoonotic and notifiable diseases, and the [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional obligations. Sepsis secondary to bite wounds from dogs or cats carries zoonotic potential, particularly in immunocompromised owners, and human exposure should prompt appropriate public health advice. | Observation | Likely Cause | Discriminating Check | |---|---|---| | Weight gain > 5% with normal perfusion | Fluid overload | Serial weights, lung auscultation, respiratory effort | | Rising CVP with static blood pressure | Vasoplegia, not hypovolemia | ScvO2 trend, lactate trend, cardiac output if available | | Persistent tachycardia after fluids | Inadequate resuscitation or pain | Lactate clearance, perfusion assessment, analgesia trial | | Worsening respiratory pattern | Pulmonary edema | SpO2, thoracic radiographs, lung ultrasound if available | | Prolonged bleeding from sites | Hemodilution or DIC | Platelet count, PT/aPTT, blood smear | ## Frequently Asked Questions ### How Should I Adapt Resuscitation Targets When Advanced Monitoring Is Unavailable? When central venous oxygen saturation monitoring is not possible, rely on serial lactate, base deficit, central venous pressure, mean arterial pressure, and urine output. The tissue perfusion parameters evaluated in dogs with severe sepsis and septic shock, including ScvO2, lactate, and base deficit, each related independently to death in one prospective ICU study, which supports their use as prognostic and therapeutic targets. Peripheral perfusion markers such as mucous membrane color, capillary refill time, and extremity temperature provide useful surrogates. Recheck lactate every two to four hours during resuscitation. A falling lactate with improving blood pressure and urine output indicates adequate perfusion even without direct oxygen delivery measurement. Document the limitations of your monitoring in the medical record. ### What Is the Role of Colloids in the Resuscitation Phase? Colloids remain a second-line option in veterinary sepsis resuscitation. The evidence comparing crystalloid and colloid fluids for microcirculatory recovery after shock is still being systematically evaluated in animal models, and no clear survival advantage has been demonstrated. Synthetic colloids carry risks of coagulopathy and acute kidney injury, particularly in septic patients with capillary leak. Natural colloids such as albumin may be considered for patients with confirmed hypoalbuminemia and ongoing fluid requirements, but availability and cost limit their use. When crystalloid alone fails to restore perfusion after an adequate volume challenge, reassess the diagnosis, consider vasopressor support, and revisit the fluid plan before adding colloids. ### How Do I Manage Fluid Therapy in a Septic Cat With Cardiac Disease? Cats with concurrent hypertrophic cardiomyopathy or other cardiac disease tolerate fluid loading poorly. Use smaller resuscitation boluses, for example 5 mL/kg over 15 minutes, and reassess perfusion and respiratory effort after each bolus. Monitor for gallop rhythms, increased respiratory rate, and crackles as early indicators of volume overload. The [AAHA and AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) emphasize individualised rate planning and frequent reassessment in small animal patients. Consider earlier transition to vasopressor support if perfusion does not improve after modest fluid volumes. Central venous pressure monitoring, where available, helps distinguish hypovolemia from cardiac dysfunction. Serial thoracic ultrasound or radiographs document pulmonary fluid accumulation before auscultatory changes appear. ### What Documentation Should I Maintain for the Fluid Therapy Plan? Record the indication for each fluid phase, the fluid type and rate, resuscitation endpoints selected, and the response to each bolus. Document cumulative fluid balance at least every eight hours during resuscitation and daily during maintenance. Note any deviations from the planned protocol and the reason for the change. The [RECOVER veterinary CPR guidelines](https://recoverinitiative.org/) demonstrate the value of structured documentation and protocol adherence in emergency settings, and the same principle applies to sepsis resuscitation. Include serial body weight, lactate, blood pressure, urine output, and central venous pressure where measured. This record supports clinical handover, identifies trends toward fluid overload, and provides defensible documentation if complications arise. ### How Should I Discuss Fluid Therapy Costs and Prognosis With an Owner? Be transparent about the expected duration of intensive care, the monitoring required, and the financial commitment across all three phases. Explain that fluid therapy is supportive while antimicrobials and source control address the infection. The association between fluid overload and increased mortality in critical care patients is well documented in human observational data, so explain that careful monitoring and staged fluid administration are intended to avoid this complication, not to reduce care. Offer a range of cost estimates based on projected hospital days and monitoring intensity. If the owner declines ICU-level care, discuss what can be achieved with limited monitoring and adjust the resuscitation endpoints accordingly. ### When Should I Stop Resuscitation Fluids and Transition to the Optimization Phase? Transition when perfusion parameters have stabilized and further fluid boluses no longer produce meaningful improvement. Indicators include normalizing lactate, improving base deficit, stable blood pressure without escalating support, and adequate urine output. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) describes the clinical assessment parameters used to guide fluid therapy decisions across species. If central venous pressure rises without corresponding improvement in perfusion, stop bolusing and consider vasopressors. In dogs with septic shock, tissue perfusion parameters measured after ICU admission predicted outcome, so reassess these values at the transition point. The transition is a clinical decision, not a fixed time point, and should be revisited whenever perfusion deteriorates again. ## Related Clinical & Scientific Guides * [Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach](/knowledge/veterinary-medicine/emergency-critical-care/toxicology-emergency-practice-common-poisons-diagnostic-approach) * [Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-cardiopulmonary-resuscitation-post-cardiac-arrest-care) * [Fluid Therapy Guidelines for Dogs and Cats: A Practical Update](/knowledge/veterinary-medicine/emergency-critical-care/fluid-therapy-guidelines-dogs-cats-practical-update) ## References and Further Reading - [A 52-year-old man with malaise and a petechial rash.](https://pubmed.ncbi.nlm.nih.gov/18722741/). 2011. - [Protocol for a systematic review of the impact of resuscitation fluids on the microcirculation after hemorrhagic shock in animal models.](https://pubmed.ncbi.nlm.nih.gov/26437713/). 2015. - [Changes in tissue perfusion parameters in dogs with severe sepsis/septic shock in response to goal-directed hemodynamic optimization at admission to ICU and the relation to outcome.](https://pubmed.ncbi.nlm.nih.gov/22731982/). 2012. - [Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.](https://pubmed.ncbi.nlm.nih.gov/6379963/). 1984. - [Antibody immunotherapy of gram-negative bacterial sepsis.](https://pubmed.ncbi.nlm.nih.gov/3299299/). 1987. - [Fluid Overload and Mortality in Adult Critical Care Patients-A Systematic Review and Meta-Analysis of Observational Studies.](https://pubmed.ncbi.nlm.nih.gov/33009098/). 2020. - [RECOVER Initiative Veterinary CPR Guidelines](https://recoverinitiative.org/). Veterinary Emergency and Critical Care Society. - [AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/). AAHA. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. ## Related Articles - [Veterinary Shock: Fluid Resuscitation Strategies](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-shock-fluid-resuscitation-strategies) - [Veterinary Fluid Therapy: Crystalloids vs Colloids](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-fluid-therapy-crystalloids-colloids) - [Subcutaneous Fluid Therapy in Dogs: Indications, Volumes, and Monitoring](/knowledge/veterinary-medicine/emergency-critical-care/subcutaneous-fluid-therapy-dogs-indications-volumes-monitoring) - [Fluid Therapy Guidelines for Dogs and Cats: A Practical Update](/knowledge/veterinary-medicine/emergency-critical-care/fluid-therapy-guidelines-dogs-cats-practical-update) - [Complications of Oxygen Therapy in Veterinary Patients](/knowledge/veterinary-medicine/emergency-critical-care/complications-oxygen-therapy-veterinary-patients) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.